BPCA
JAZZ icon

Bank Pictet & Cie (Asia)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bank Pictet & Cie (Asia)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,148
Closed -$613K – 87
2020
Q1 		$613K Hold
6,148
– – 0.3% 61
2019
Q4 		$918K Buy
+6,148
New +$837K 0.39% 55

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank Pictet & Cie (Asia)'s JAZZ Position: Q2 2020 in Review

Bank Pictet & Cie (Asia) sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 6,148 shares — an estimated $613K sold.

Bank Pictet & Cie (Asia) first reported a position in JAZZ in Q4 2019 and held it in 2 quarters. The position peaked at $918K in Q4 2019. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Bank Pictet & Cie (Asia) reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Bank Pictet & Cie (Asia) sold 6,148 Jazz Pharmaceuticals shares in Q2 2020, an estimated $613K.
  • Bank Pictet & Cie (Asia) first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Bank Pictet & Cie (Asia)'s Jazz Pharmaceuticals position peaked at $918K in Q4 2019.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2020, filed 13 Aug 2020.